Published: 2016-08-01
Review
The Association between ANXA11 Gene Polymorphisms and Sarcoidosis: a Meta-Analysis and systematic review
Abstract 266 | PDF Downloads 75Page 102-111
An epidemiological perspective of the pathology and etiology of sarcoidosis
Abstract 1451 | PDF Downloads 263Page 112-116
Original Articles: Clinical Research
High-resolution CT predictors of hypersensitivity pneumonitis
Abstract 420 | PDF Downloads 441Page 117-123
Fatigue and health-related quality of life in patients with pulmonary sarcoidosis treated by oral Corticosteroids
Abstract 325 | PDF Downloads 472Page 124-129
Fatigue in sarcoidosis and idiopathic pulmonary fibrosis: differences in character and severity between diseases
Abstract 277 | PDF Downloads 302Page 130-138
Serum fibroblastic growth factor 23 in acute Sarcoidosis and normal kidney function
Abstract 195 | PDF Downloads 120Page 139-142
Platelet aggregability in patients with interstitial pneumonias
Abstract 199 | PDF Downloads 155Page 143-150
Evaluation of Tpeak-Tend interval and Tpeak-end/QT ratio in patients with Sarcoidosis
Abstract 302 | PDF Downloads 189Page 151-156
Exercise related ventilation dynamics and clinical correlates in patients with fibrotic idiopathic interstitial pneumonias
Abstract 288 | PDF Downloads 135Page 157-165
Case Reports
Polishing surgical metal pieces, granulomatosis and mineralogical analysis
Abstract 215 | PDF Downloads 113Page 166-170
Pulmonary metastases from low grade sarcoma in a patient with pulmonary sarcoidosis. Sarcoidosis or sarcoid-like reaction?
Abstract 245 | PDF Downloads 169Page 171-174
Cardiac sarcoidosis – silent destroyer.
Abstract 222 | PDF Downloads 146Page 175-177
Sarcoidosis during etanercept treatment for rheumatoid arthritis in women with a history of bilateral oophorectomy
Abstract 608 | PDF Downloads 109Page 178-181
Extensive pulmonary sarcoid reaction in a patient with BMPR-2 associated idiopathic pulmonary arterial hypertension
Abstract 194 | PDF Downloads 55Page 182-185
Successful management of acute respiratory failure in an Idiopathic Pulmonary Fibrosis patient using an extracorporeal carbon dioxide removal system
Abstract 248 | PDF Downloads 113Page 186-190
Letter to Editor
Repositioning ‘old’ drugs to treat rare diseases: arguing from the mechanism of action
Abstract 394 | PDF Downloads 115Page 191-194